Clinical study on the correlation between novel coronavirus pneumonia (COVID-19) clinical rehabilitation assessment and prognosis

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031214

Enrollment

Unknown

Registered

2020-03-24

Start date

2020-03-31

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) a patient who meets the diagnostic criteria of novel coronavirus pneumonia and is confirmed by lung CT or nucleic acid examination; (2) stable condition, normal cognitive function, able to understand tests and requirements; (3) willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) patients with severe basic diseases and intolerance such as cardiopulmonary function; (2) patients combined with diseases affecting the assessment; with communication and cognitive impairment, unclear consciousness and unable to cooperate with the experiment.

Design outcomes

Primary

Measure	Time frame
Modified dyspnea index scale;St.George's Respiratory Questionnaire;Self-Rating Depression Scale;	—

Secondary

Measure	Time frame
Pulmonary function assessment scale;Pneumonia rating scale ;self-rating anxiety scale;	—

Countries

China

Contacts

Public ContactGAO Tian-lin

The First Rehabilitation Hospital of Shanghai

2235658154@qq.com+86 18930132792

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026